The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
about
Emerging drugs for Guillain-Barré syndromeGuillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisIVIG treatment and prognosis in Guillain-Barré syndromeNeurologic symptoms associated with cattle farming in the Agricultural Health StudyCrystal Structure and Catalytic Mechanism of PglD from Campylobacter jejuniWhat was the cause of Franklin Delano Roosevelt's paralytic illness?Zika Virus Infection and Guillain-Barré Syndrome in Three Patients from SurinameGuillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbitsOccupational exposure to swine, poultry, and cattle and antibody biomarkers of Campylobacter jejuni exposure and autoimmune peripheral neuropathyGuillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the DeGuillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe[Guillain-Barré syndrome after exposure to influenza].Clinical applications of therapeutic apheresis.Neurologic indications for therapeutic plasma exchange: an update.Neurologic indications for therapeutic plasma exchange: 2011 update.Neurologic indications for therapeutic plasma exchange: 2013 update.Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.Commonality and biosynthesis of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni.Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity.Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.Association of anti-gangliosides antibodies and anti-CMV antibodies in Guillain-Barré syndrome.New concepts of Guillain-Barré syndrome.Detection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barre syndrome.Guillain Barré syndrome.Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.Retrospective analysis of Guillain-Barré syndrome and Fisher syndrome after the Great East Japan Earthquake.Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders.Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms.The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.Treatment guidelines for Guillain-Barré Syndrome.Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchangeAnti-GQ1b IgG antibody syndrome: clinical and immunological range.Management of inflammatory neuropathiesEnteric campylobacter: purging its secrets?
P2860
Q22241376-3A2342D5-E9FC-4A74-9543-3E8B3E9C1BC5Q22251013-D7FE564D-205E-4C48-8409-72D868ED44D5Q22252627-277343DA-0EDF-4C83-BB44-4B72C9D98E32Q23916864-DDC49186-0441-4E9E-90C4-47F068148CECQ27651382-8E6252A2-A42B-46DE-876D-CDA23E9B844CQ28210423-49DA2F2F-D517-4051-990D-E9C7EA5B61A3Q28353939-BDA126B9-2548-44EE-BD68-2E23FDB80B5BQ28360460-88C001D8-7FDD-4691-940C-C790FFA334CAQ28395659-C167357F-93FE-458A-BD5F-FCC7A37AF7A7Q30351998-BAEF095D-6E34-413B-902D-7C8891CAD10AQ30359034-58774B7D-01CD-4F18-955F-A2EFF62868C4Q30404728-B1459823-C7D0-4C47-87D8-8501205C9083Q30415924-6630F6D1-0E84-47F6-904C-145859CAA91CQ30451700-FD2BBADC-26DB-4FE6-8A03-923457FC7B88Q30454297-67F583C0-F6D0-4D5E-A8C9-59D7CB745AAFQ30455391-EBB3315F-4E6F-4D7B-B168-A0F512239BB7Q30458271-8514166F-3CDA-4029-987E-F6C9A09C0535Q33280997-7B509C79-FC77-4387-91C3-CC9DA1AE2BE5Q33293042-B73260AC-F98C-47A2-9F42-B8A006FD9050Q33301762-F6958EEB-D42B-46D7-8AA3-431F2E9F229EQ33592337-553D5495-6ED4-43CF-AE4D-AF2283138C18Q33672114-B2827539-4342-400B-A113-D310EA823CD6Q33695363-360EFFA3-0843-4504-86B8-DED94856B987Q33886911-A85D0D93-EC67-4E75-8DFF-6F652F9DBE52Q33909538-3D60D892-EC9B-4AA4-A47E-B5384EDF14F2Q33918862-954020ED-A280-4C53-8CEA-9EDB8A58D8F2Q33967481-607A2394-6A53-441A-8134-B630CF0AB8B1Q34025060-09EFA3B4-A535-42AE-89D7-2177CA83DBBEQ34356146-CF54580E-C11F-4EB1-B592-17D50F9EBAD3Q34405976-6B1A8720-B2B4-433B-A3A4-666BDDEC68A1Q34416948-41D0AB31-58D6-4FE4-ADBF-5AA3761F6DBEQ34677183-EC968710-B002-49DA-8259-2847C609AA5BQ34700616-E7CD937B-EF14-4B78-8494-F87DB75A55D5Q34720405-AC8CA5D6-9011-4BEA-8CED-92D78763D613Q34805017-9B9D7BD8-55F5-4D50-9A3C-45B8C6C08A64Q35152989-95514E0F-D12C-4A35-B1FF-E9AFF4EB76FFQ35549851-1BBCF18E-BB59-4AF0-9CCB-03A6874D381FQ35572316-BAB38E49-1DB8-4C78-A0B8-A01D3604E8F8Q35576432-3F64A476-9A91-4A83-BFBD-6D8B69BF2B0AQ35578820-7ECB2E3D-A11C-45CF-AC3F-A688B9964F3A
P2860
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@ast
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@en
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@en-gb
type
label
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@ast
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@en
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@en-gb
prefLabel
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@ast
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@en
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@en-gb
P2093
P3181
P356
P1433
P1476
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
@en
P2093
B. C. Jacobs
M. A. de Klerk
P. A. van Doorn
P. H. Rothbarth
P. Herbrink
P. I.M. Schmitz
P304
P3181
P356
10.1212/WNL.51.4.1110
P407
P577
1998-10-01T00:00:00Z